Sixth Wave (SIXW.C) announced today that it has received additional grant funding for its joint research project with York University. “The grant provides the Company a significant opportunity to…
Pharmaceuticals
In this episode, we take to look at Element Nutritional Sciences (ELMT.C) a nutraceutical company that uses plant-based technology and extensive nutritional research to create health-driven products for customers….
Protagonist Therapeutics (PTGX.Q) announced the receipt of verbal communication from the U.S. Food and Drug Administration (FDA) that the Company’s clinical studies for rusfertide have been placed on a…
Innate Pharma S.A. (IPHA.Q) announced today that AstraZeneca has presented results from the randomized COAST Phase 2 trial during the European Society for Medical Oncology (ESMO) Congress 2021 on…
Leap Therapeutics (LPTX.Q) announced today that it will be presenting initial data from the first-line cohort of the DisTinGuish study at the European Society for Medical Oncology (ESMO) Congress….
Filament Health (FH.NEO) got the nod from the Financial Regulatory Authority to start trading on the OTC Pink Market in the United States under the symbol “FLHLF,” and has…
Adaptimmune Therapeutics (ADAP.Q) announced today that it has entered into a strategic collaboration and license agreement with Genentech, a member of the Roche Group, to develop and commercialize allogenic…
Filament Health (FH.NEO) filed their 20th patent application for their research phase programs, including three international Patent Cooperation Treaty (PCT) applications, earlier this week, according to a press release….
Vancouver’s own Jody Vance speaks with Ken d’Entremont, Medexus Pharmaceuticals (MDP.V) CEO and director, to find out more about the company’s mandate of bringing established drugs approved in other…
XPhyto Therapeutics (XPHY.C), with its partner and acquisition target, 3a-diagnostics GmbH announced today that it has successfully registered its first biosensor test in oral inflammation with the German authorities….